Funder
National Eye Institute
Knights Templar Eye Foundation
Research to Prevent Blindness
Deutsche Forschungsgemeinschaft
National Institutes of Health
Reference13 articles.
1. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy;Gu;Nat Genet,1997
2. Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration;Thompson;Invest Ophthalmol Vis Sci,2000
3. Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial;Maguire;Lancet,2009
4. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial;Russell;Lancet,2017
5. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation–associated inherited retinal dystrophy: results of phase 1 and 3 trials;Maguire;Ophthalmology,2019
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献